WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | Return to index | ||||||||
Order | Gene | Description | ref_hepatocyte | HepG2 | HepG2.C3A | HuH.7 | SNU475 | THLE | liver |
1 | SERPINE1 | Plasminogen activator inhibitor 1 | [1] | -0.70[2] | -0.27[3] | -5.63[4] | -6.06[5] | 0.07[6] | -4.59[7] |
2 | SHC1 | SHC-transforming protein 1 | [8] | -0.67[9] | -0.24[10] | 1.21[11] | 0.40[12] | -0.66[13] | 0.07[14] |
3 | FLNA | Filamin-A | [15] | 2.29[16] | 0.96[17] | -0.60[18] | 3.29[19] | 1.38[20] | 1.45[21] |
4 | TGFBR2 | TGF-beta receptor type-2 | [22] | 0.98[23] | 0.66[24] | 1.69[25] | -1.19[26] | -0.02[27] | 0.80[28] |
5 | MAPK1 | Mitogen-activated protein kinase 1 | [29] | -0.13[30] | 0.22[31] | 1.43[32] | -0.40[33] | -1.30[34] | 1.07[35] |
6 | MAPK14 | Mitogen-activated protein kinase 14 | [36] | -0.36[37] | -0.08[38] | 0.87[39] | -0.57[40] | -1.64[41] | 0.58[42] |
7 | MAPK8 | Mitogen-activated protein kinase 8 | [43] | -3.28[44] | -1.66[45] | -1.41[46] | -3.16[47] | -3.84[48] | -1.22[49] |
8 | AGTR1 | Type-1 angiotensin II receptor | [50] | -9.19[51] | -7.14[52] | -0.25[53] | -3.52[54] | -8.47[55] | 0.73[56] |
9 | SMAD3 | Mothers against decapentaplegic homolog 3 | [57] | 0.09[58] | -0.30[59] | 1.31[60] | -0.46[61] | -0.12[62] | -0.50[63] |
10 | TGFBR1 | TGF-beta receptor type-1 | [64] | -1.51[65] | -1.07[66] | -0.19[67] | -1.91[68] | -1.35[69] | 0.62[70] |
11 | MAPK3 | Mitogen-activated protein kinase 3 | [71] | 0.01[72] | 0.27[73] | 1.69[74] | -1.83[75] | -2.35[76] | -1.75[77] |
12 | SMAD4 | Mothers against decapentaplegic homolog 4 | [78] | -0.44[79] | 0.40[80] | 1.74[81] | -0.34[82] | -0.52[83] | 2.08[84] |
13 | SMAD2 | Mothers against decapentaplegic homolog 2 | [85] | 0.18[86] | 0.65[87] | 1.53[88] | 0.13[89] | -0.23[90] | 1.86[91] |
14 | TGFBR3 | Transforming growth factor beta receptor type 3 | [92] | 0.45[93] | 2.71[94] | 2.66[95] | -0.40[96] | -2.62[97] | 2.27[98] |
15 | LTBP1 | Latent-transforming growth factor beta-binding protein 1 | [99] | -2.59[100] | -8.44[101] | -1.02[102] | 0.01[103] | -0.32[104] | 1.68[105] |
16 | ENG | Endoglin | [106] | -2.73[107] | -0.72[108] | -5.35[109] | 0.80[110] | -3.60[111] | 3.20[112] |
17 | NR2C2 | Nuclear receptor subfamily 2 group C member 2 | [113] | 1.40[114] | 2.32[115] | 4.16[116] | 1.45[117] | 1.27[118] | 3.74[119] |
18 | FBN1 | Fibrillin-1 | [120] | 1.22[121] | -0.50[122] | 3.42[123] | 4.09[124] | 6.50[125] | 6.69[126] |
19 | LTBP2 | Latent-transforming growth factor beta-binding protein 2 | [127] | 3.88[128] | 1.77[129] | 3.30[130] | 4.42[131] | 2.69[132] | 3.11[133] |
20 | POSTN | Periostin | [134] | -5.61[135] | -4.29[136] | -2.00[137] | 5.75[138] | 3.23[139] | 2.73[140] |
21 | ANGPT2 | Angiopoietin-2 | [141] | -3.56[142] | -2.11[143] | -0.17[144] | -2.76[145] | -3.28[146] | 4.29[147] |
22 | FBN2 | Fibrillin-2 | [148] | -0.67[149] | [150] | -3.07[151] | 2.09[152] | 4.37[153] | 3.15[154] |
23 | RUNX2 | Runt-related transcription factor 2 | [155] | -2.68[156] | -2.83[157] | 3.62[158] | 4.87[159] | 6.28[160] | 2.91[161] |
24 | FBN3 | Fibrillin-3 | [162] | 1.76[163] | 5.00[164] | 4.04[165] | -5.29[166] | [167] | 0.02[168] |
25 | CCN2 | [169] | [170] | [171] | [172] | [173] | [174] | [175] |